Increased in vivo efficacy by A2AR-knockdown CAR T cells was associated with increased expression of effector-related genes in tumor-infiltrating CD8+NGFR+ CAR T cells such as IFNγ, TNF, IRF4, and Granzyme B (Fig. 3B, C). This evidence concerns the gene ADORA2A and neoplasm.